Page last updated: 2024-08-21

podophyllotoxin and AIDS Seroconversion

podophyllotoxin has been researched along with AIDS Seroconversion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruno Ventre, M; Caligaris-Cappio, F; Cattaneo, C; Di Nicola, M; Donadoni, G; Ferreri, AJ; Foppoli, M; Fumagalli, L; Govi, S; Mappa, S; Re, A; Rossi, G; Spina, M; Tirelli, U1
Adomeit, A; Bender, HG; Bodden-Heidrich, R; Koldovsky, U; Küppers, V; von Eckardstein, S; Wingartz, C1

Reviews

1 review(s) available for podophyllotoxin and AIDS Seroconversion

ArticleYear
[Diagnostic and therapeutic concepts of HPV infection in HIV-positive women].
    Zentralblatt fur Gynakologie, 1999, Volume: 121, Issue:1

    Topics: Comorbidity; Condylomata Acuminata; Female; HIV Seropositivity; Humans; Laser Therapy; Papillomaviridae; Papillomavirus Infections; Podophyllotoxin; Tumor Virus Infections

1999

Other Studies

1 other study(ies) available for podophyllotoxin and AIDS Seroconversion

ArticleYear
Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
    British journal of haematology, 2012, Volume: 159, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cytarabine; Female; HIV Seropositivity; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Stem Cell Transplantation; Transplantation, Autologous

2012